Dermatology and Venereology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
Dermatology and Venereology Department, El Menshawy General Hospital, Tanta, Egypt.
Dermatol Ther. 2020 Nov;33(6):e14488. doi: 10.1111/dth.14488. Epub 2020 Nov 9.
Lyophilized-growth factors (L-GFs), is a new platelet rich plasma (PRP) preparation that is standardized in growth factors concentrations. The aim of this study was to compare the therapeutic efficacy of ablative fractional CO laser in combination with L-GFs vs PRP in post-acne scars. This study was conducted on 45 patients presented with facial post-acne scars. Each patient received three sessions of fractional CO laser on both sides of the face followed by topical application of L-GFs on one side and conventional PRP on the other side. Assessment was done before and after treatment semiquantitatively by Echella d'Èvaluation Clinique des Cicatrices d'Acné (ECCA) score and qualitatively by Goodman and Baron's qualitative scar (GBQS) scale, in addition to dermoscopic evaluation. The current study reported significant clinical improvement of post-acne scars on both sides of the face evidenced by significant reduction of both ECCA score and GBQS scale with minimal side effects. The degree of clinical improvement and patients' satisfaction were significantly higher with shorter downtime in response to fractional CO laser combined with L-GFs rather than its combination with PRP. In conclusion, laser assisted delivery of L-GFs via fractional CO laser could be considered a novel successful therapeutic modality for post-acne scars.
冻干生长因子(L-GFs)是一种新的血小板丰富血浆(PRP)制剂,其生长因子浓度标准化。本研究旨在比较消融性 CO2 激光联合 L-GFs 与 PRP 治疗痤疮后瘢痕的疗效。这项研究共纳入了 45 名面部痤疮后瘢痕患者。每位患者接受了三次双侧消融性 CO2 激光治疗,随后一侧给予 L-GFs 局部外用,另一侧给予常规 PRP。治疗前后通过 Echella d'Èvaluation Clinique des Cicatrices d'Acné(ECCA)评分进行半定量评估,通过 Goodman 和 Baron 的定性瘢痕(GBQS)评分进行定性评估,并进行皮肤镜评估。本研究报道了痤疮后瘢痕的显著临床改善,双侧 ECCA 评分和 GBQS 评分均显著降低,且副作用最小。与联合 PRP 相比,联合 L-GFs 的 CO2 激光治疗具有更高的临床改善程度和患者满意度,且停机时间更短。总之,通过消融性 CO2 激光辅助 L-GFs 的传递可以被认为是一种治疗痤疮后瘢痕的新的成功治疗方法。